✦ LIBER ✦

Prolonged indomethacin treatment in preterm infants with symptomatic patent ductus arteriosus: efficacy, drug level monitoring, and patient selection

✍ Scribed by A. Leonhardt; V. Isken; P. G. Kühl; H. W. Seyberth

Publisher: Springer
Year: 1987
Tongue: English
Weight: 585 KB
Volume: 146
Category: Article
ISSN: 0340-6997
DOI: 10.1007/bf02343219

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of patent ductus arteriosus and i

Effect of patent ductus arteriosus and indomethacin treatment on serum cardiac troponin T levels in preterm infants with respiratory distress syndrome

✍ D. Trevisanuto; M. Zaninotto; M. Lachin; S. Altinier; M. Plebani; P. Ferrarese; 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 155 KB

Introduction of plasma indomethacin leve

Introduction of plasma indomethacin level monitoring and evaluation of an effective threshold level in very low birth weight infants with symptomatic patent ductus arteriosus

✍ H. W. Seyberth; G. Knapp; D. Wolf; H. E. Ulmer 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 676 KB

First results are described of individually tailored indomethacin dose rates employing on-line drug level monitoring for pharmacologically induced ductal constriction in very low birth weight infants with symptomatic patent ductus arteriosus (sPDA). In addition prolonged indomethacin therapy was int